These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37423341)

  • 1. Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy.
    Hu A; Lloyd M; Loke P; Chebar Lozinsky A; O'Sullivan M; Quinn P; Gold M; Tang MLK
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3195-3202.e4. PubMed ID: 37423341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers.
    Nowak-Wegrzyn A; Hass SL; Donelson SM; Robison D; Cameron A; Etschmaier M; Duhig A; McCann WA
    World Allergy Organ J; 2021 Feb; 14(2):100512. PubMed ID: 33664934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
    Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
    JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What affects quality of life among caregivers of food-allergic children?
    Howe L; Franxman T; Teich E; Greenhawt M
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):69-74.e2. PubMed ID: 24950845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post hoc analysis examining symptom severity reduction and symptom absence during food challenges in individuals who underwent oral immunotherapy for peanut allergy: results from three trials.
    Blumchen K; Kleinheinz A; Klimek L; Beyer K; Anagnostou A; Vogelberg C; Butovas S; Ryan R; Norval D; Zeitler S; Du Toit G
    Allergy Asthma Clin Immunol; 2023 Mar; 19(1):21. PubMed ID: 36915184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study.
    Dua S; Ruiz-Garcia M; Bond S; Durham SR; Kimber I; Mills C; Roberts G; Skypala I; Wason J; Ewan P; Boyle R; Clark A
    J Allergy Clin Immunol; 2019 Dec; 144(6):1584-1594.e2. PubMed ID: 31319102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
    DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy.
    Wensing M; Penninks AH; Hefle SL; Koppelman SJ; Bruijnzeel-Koomen CA; Knulst AC
    J Allergy Clin Immunol; 2002 Dec; 110(6):915-20. PubMed ID: 12464959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliciting dose is associated with tolerance development in peanut and cow's milk allergic children.
    Nitsche C; Westerlaken-van Ginkel CD; Kollen BJ; Sprikkelman AB; Koppelman GH; Dubois AEJ
    Clin Transl Allergy; 2019; 9():58. PubMed ID: 31709035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life.
    Deschildre A; Elegbédé CF; Just J; Bruyère O; Van der Brempt X; Papadopoulos A; Beaudouin E; Renaudin JM; Crepet A; Moneret-Vautrin DA
    Clin Exp Allergy; 2016 Apr; 46(4):610-20. PubMed ID: 26588036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender, prick test size and rAra h 2 sIgE level may predict the eliciting dose in patients with peanut allergy: Evidence from the Mirabel survey.
    Elegbede CF; Papadopoulos A; Just J; Moneret-Vautrin DA; Deschildre A; Crépet A
    Clin Exp Allergy; 2019 May; 49(5):677-689. PubMed ID: 30689235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting reactivity threshold in children with anaphylaxis to peanut.
    Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
    Clin Exp Allergy; 2018 Apr; 48(4):415-423. PubMed ID: 29284183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Health and Economic Outcomes of Peanut Allergy Management Practices.
    Shaker M; Greenhawt M
    J Allergy Clin Immunol Pract; 2018; 6(6):2073-2080. PubMed ID: 29751153
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.